ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 684405 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 684405; 2) Community: the network communities that were significantly associated with the response to NSC 684405; 3) Molecule: the relationships between components within communities and NSC 684405; 4) MDR: the compounds that were significantly associated with the NSC 684405.

NSC Compound Enrichment Correlation
NSC 72961 8-Azadenosine 0.00265144454581183 0.32484902
NSC 762559 Null 0.00265144454581183 -0.25996726
NSC 629868 Null 0.00286159651545682 -0.094853486
NSC 670783 Null 0.00286159651545682 0.3716743
NSC 724780 (1S,4R,5R,12R,13S)-9-[(2-{[(1S,4R,5R,8R,12R,13S)-1,5-dimethy l)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadec -9-en-9-yl]methoxy}ethoxy)methyl]-1,5-dimethyl-10-(trifluoro methyl)-11,14,15 0.00286159651545682 0.26944444
NSC 372944 Null 0.0035949310449002 0.30874657
NSC 745062 Null 0.00359493104490023 0.23751608
NSC 180973 Tamoxifen citrate 0.0050112111746529 0.26652593
NSC 750970 3-[(E)-1-(3-1-[(4-fluorophenyl)sulfonyl]-4-piperidylimidazo[1,5-a]pyridin-1-yl)methylidene]-2-indolinone 0.00526022686151163 -0.38968401
NSC 649270 Benzo[d]naphtho[1,2-b]pyran-6-one, 1-hydroxy-10-methyl-7,8,9,10-tetrahydro- 0.00559873245069072 -0.38701873
Total:38  Current:2    [First] [Prev] [Next] [Last]